SIC 2833 – Medicinal Chemicals and Botanical Products
| Valuation | |
|---|---|
| Market Cap ($M) | 77.95 |
| Enterprise Value ($M) | 74.99 |
| Book Value ($M) | 8.22 |
| Book Value / Share | 0.63 |
| Price / Book | 9.48 |
| NCAV ($M) | 7.89 |
| NCAV / Share | 0.61 |
| Price / NCAV | 9.87 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.52 |
| Return on Assets (ROA) | -0.34 |
| Return on Equity (ROE) | -0.36 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 41.92 |
| Current Ratio | 41.92 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 8.11 |
| Assets | 8.44 |
| Liabilities | 0.22 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -4.74 |
| Net Income | -4.30 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -4.00 |
| Cash from Investing | 5.24 |
| Cash from Financing | 0.10 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 23,354 | 107,355 | 21.75 | |
| 3,352 | 11,303 | 29.66 | |
| 8,925 | 42,787 | 20.86 | |
| 12,013 | 57,517 | 20.89 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| QLGN – Qualigen Therapeutics, Inc. | RENB – Renovaro Inc. |
| REVB – Revelation Biosciences, Inc. | RGLS – Regulus Therapeutics Inc. |
| RMTI – Rockwell Medical, Inc. |
Financial data and stock pages provided by
Fintel.io